Viewing Study NCT06050356


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2025-12-25 @ 9:20 PM
Study NCT ID: NCT06050356
Status: RECRUITING
Last Update Posted: 2025-05-13
First Post: 2023-09-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b
Sponsor: Statens Serum Institut
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module